サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1747882

ペット用ワクチンの世界市場

Pet Vaccines

出版日
ページ情報
英文 271 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
ペット用ワクチンの世界市場
出版日: 2025年06月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 271 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ペット用ワクチンの世界市場は2030年までに91億米ドルに達する見込み

2024年に71億米ドルと推定されるペット用ワクチンの世界市場は、分析期間2024-2030年にCAGR 4.0%で成長し、2030年には91億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるカンランワクチンは、CAGR 3.3%を記録し、分析期間終了時には60億米ドルに達すると予測されます。猫用ワクチン分野の成長率は、分析期間中CAGR 5.7%と推定されます。

米国市場は19億米ドルと推定、中国はCAGR 7.3％で成長予測

米国のペット用ワクチン市場は、2024年には19億米ドルになると推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.1%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界のペット用ワクチン市場- 主要動向と促進要因のまとめ

ペット用ワクチンが人獣共通感染症のリスク認識と予防獣医療の時代に重要なのはなぜか？

ペット用ワクチンは、ペットの飼い主、獣医師、公衆衛生当局が病気の予防、長寿、人獣共通感染症リスクの軽減をより重視するようになり、世界的に需要が高まっています。ワクチンは、狂犬病、ジステンパー、パルボウイルス、猫白血病、犬小屋咳などの伝染病や致死的な病気に対する最前線の防御手段です。都市化が進み、人間とペットの同居がより密接になるにつれ、予防接種はもはや獣医学上の推奨事項ではなく、コンパニオンアニマル・ケアにおける規制および倫理上の必須事項となっています。

COVID-19の大流行により、種間感染に対する認識が高まり、政府も個人もワクチン接種スケジュールをより厳格に守るようになりました。多くの管轄区域では狂犬病の予防接種が義務付けられており、また他の管轄区域では飼育、旅行、養子縁組の際に予防接種の証明を義務付けています。これらの規制は、ペットヘルスケアを専門化するためのより広範な取り組みとともに、猫、犬、エキゾチックコンパニオンアニマルのウェルネスプロトコルの標準的な構成要素として、コアワクチンと非コアワクチンの役割を強化しています。

送達方法、製剤、混合ワクチンの革新はコンプライアンスをどのように向上させているか？

ワクチン製剤と送達における技術的進歩は、有効性を改善し、副作用を低減し、飼い主と獣医師のコンプライアンスを向上させています。現在、MLV（Modified-Live Virus）ワクチンや遺伝子組換えワクチンは、より少ない副反応でより広範な免疫防御を提供しています。特に猫や小型犬では、注射部位の不快感やストレスを最小限に抑えるため、経鼻・経皮投与システムの開発も進められています。

DAPP（ジステンパー、アデノウイルス、パラインフルエンザ、パルボウイルス）やFVRCP（猫ウイルス性鼻気管炎、カリシウイルス、汎白血球減少症）のような混合ワクチンは、その利便性と広範な予防効果から広く受け入れられています。これらの製剤は、獣医師の診察や注射の回数を減らし、飼い主のアドヒアランスと動物の福祉を向上させます。さらに、メーカーは、特に慢性的な健康状態や高齢のペットの炎症やアレルギー反応を最小限に抑えながら、免疫反応を高めるアジュバント技術に投資しています。

なぜコンパニオンアニマルヘルスケアのエコシステムと新興市場力学がアクセスと普及を促進するのか？

組織化された獣医療ネットワーク、モバイルワクチンクリニック、ペット保険、スマートスケジューリングアプリの台頭は、ペット用ワクチンへの幅広いアクセスを可能にしています。北米や欧州では、年1回の健康診断がバンドルされたウェルネス・プランが一般的になり、一貫した予防接種が奨励されています。一方、インド、ブラジル、東南アジアなどの新興国では、所得の上昇と都市部でのペット飼育が、政府支援の手ごろな予防接種プログラムに対する需要を引き起こしています。

非政府組織（NGO）、国際的な動物福祉機関、公衆衛生当局も、十分なサービスを受けていない地域での予防接種の普及に重要な役割を果たしています。狂犬病の集団予防接種キャンペーン、街頭犬への予防接種活動、教育的イニシアティブは、地域全体の疾病予防のためのスケーラブルなモデルを作り出しています。獣医の遠隔医療、訪問サービス、電子薬局のプラットフォームは、ワクチンへのアクセスをより合理化し、ペットの飼い主の敷居を低くしています。

ペット用ワクチン市場の世界的拡大の原動力は？

ペット用ワクチン市場の成長は、世界のペット数の増加、人獣共通感染症に対する意識の高まり、組織化されたペットヘルスケアの枠組みの普及など、いくつかの要因によってもたらされています。主な成長要因は、標準的な獣医療サービスと消費者の期待に予防医療が統合されたことであり、消極的な治療から積極的な疾病管理へと重点が移行しています。

ワクチン技術の開発、獣医学的インフラの拡大、先進国市場と新興国市場の双方における官民の取り組みが、旺盛な需要環境を生み出しています。規制当局の支援、デジタルヘルスケアの統合、ペットの健康に対する消費者主導の支出が融合することで、ペット用ワクチン市場は世界的に持続的な成長を遂げる位置にあります。予防接種が責任あるペットの子育てと国民の健康戦略の中心になるにつれ、ワクチンは予防獣医療の要であり続けるでしょう。

セグメント

種類（カンレーン、ネコ）;用途（犬、猫、ウサギ、その他の用途）

調査対象企業の例（全34件）

  • Bayer AG
  • Bimeda Biologicals
  • Boehringer Ingelheim
  • Calier
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health
  • Hester Biosciences Limited
  • HIPRA
  • Intervet（MSD Animal Health）
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Sanofi
  • Tianjin Ringpu Biotechnology Co., Ltd.
  • Vaxxinova
  • Veterquimica
  • Vetoquinol
  • Virbac
  • Zoetis Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP35512

Global Pet Vaccines Market to Reach US$9.1 Billion by 2030

The global market for Pet Vaccines estimated at US$7.1 Billion in the year 2024, is expected to reach US$9.1 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Canlane Vaccines, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$6.0 Billion by the end of the analysis period. Growth in the Feline Vaccines segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 7.3% CAGR

The Pet Vaccines market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Pet Vaccines Market - Key Trends & Drivers Summarized

Why Are Pet Vaccines Critical in the Era of Zoonotic Risk Awareness and Preventive Veterinary Care?

Pet vaccines are experiencing rising demand globally as pet owners, veterinarians, and public health authorities place stronger emphasis on disease prevention, longevity, and zoonotic risk mitigation. Vaccines form the frontline defense against contagious and potentially fatal diseases such as rabies, distemper, parvovirus, feline leukemia, and kennel cough. With increased urbanization and closer human-pet cohabitation, immunization is no longer just a veterinary recommendation-it’s a regulatory and ethical imperative in companion animal care.

The COVID-19 pandemic has elevated awareness of interspecies disease transmission, pushing both governments and individuals to adhere more strictly to vaccination schedules. In many jurisdictions, rabies vaccination is mandatory, while others require proof of immunization for boarding, travel, and adoption. These regulations, along with broader efforts to professionalize pet healthcare, are reinforcing the role of core and non-core vaccines as standard components of wellness protocols across cats, dogs, and exotic companion animals.

How Are Innovations in Delivery Methods, Formulations, and Combination Vaccines Enhancing Compliance?

Technological advances in vaccine formulation and delivery are improving efficacy, reducing side effects, and enhancing compliance among pet owners and veterinarians. Modified-live virus (MLV) and recombinant vaccines now offer broader immune protection with fewer adverse reactions. Intranasal and transdermal delivery systems are also being developed to minimize injection site discomfort and stress, particularly in cats and small-breed dogs.

Combination vaccines, such as DAPP (Distemper, Adenovirus, Parainfluenza, Parvovirus) or FVRCP (Feline Viral Rhinotracheitis, Calicivirus, Panleukopenia), are gaining wide acceptance for their convenience and broad-spectrum protection. These formulations reduce the number of veterinary visits and injections required, improving owner adherence and animal welfare. Additionally, manufacturers are investing in adjuvant technologies that enhance immune response while minimizing inflammation or allergic reactions, especially in pets with chronic health conditions or advanced age.

Why Are Companion Animal Healthcare Ecosystems and Emerging Market Dynamics Driving Access and Uptake?

The rise of organized veterinary care networks, mobile vaccination clinics, pet insurance coverage, and smart scheduling apps is enabling wider access to pet vaccines. Wellness plans bundled with annual check-ups are now common in North America and Europe, encouraging consistent immunization. Meanwhile, in emerging economies such as India, Brazil, and Southeast Asia, rising incomes and urban pet adoption are triggering demand for affordable, government-supported immunization programs.

Non-governmental organizations (NGOs), international animal welfare agencies, and public health authorities are also playing a pivotal role in extending vaccination coverage in underserved areas. Mass rabies vaccination campaigns, street dog immunization drives, and educational initiatives are creating scalable models for community-wide disease prevention. Veterinary telemedicine, doorstep services, and e-pharmacy platforms are making vaccine access more streamlined and less intimidating for pet owners.

What’s Fueling the Global Expansion of the Pet Vaccines Market?

The growth in the pet vaccines market is driven by several factors including the increasing global pet population, heightened awareness of zoonotic diseases, and the proliferation of organized pet healthcare frameworks. A major growth driver is the integration of preventive care into standard veterinary services and consumer expectations-shifting the focus from reactive treatment to proactive disease management.

Advancements in vaccine technology, expansion of veterinary infrastructure, and public-private initiatives in both developed and developing markets are creating a robust demand environment. With the convergence of regulatory support, digital healthcare integration, and consumer-driven spending on pet wellness, the pet vaccines market is positioned for sustained global growth. As immunization becomes central to responsible pet parenting and population health strategy, vaccines will remain the cornerstone of preventive veterinary medicine.

SCOPE OF STUDY:

The report analyzes the Pet Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Canlane, Feline); Application (Dogs, Cats, Rabbits, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Bayer AG
  • Bimeda Biologicals
  • Boehringer Ingelheim
  • Calier
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health
  • Hester Biosciences Limited
  • HIPRA
  • Intervet (MSD Animal Health)
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Sanofi
  • Tianjin Ringpu Biotechnology Co., Ltd.
  • Vaxxinova
  • Veterquimica
  • Vetoquinol
  • Virbac
  • Zoetis Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Pet Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Pet Ownership and Companion Animal Spending Drives Demand for Preventive Veterinary Vaccinations
    • Expansion of Companion Animal Zoonosis Awareness Throws the Spotlight on Core and Non-Core Pet Vaccines
    • OEM Innovation in Recombinant and DNA-Based Pet Vaccines Enhances Safety and Immune Efficacy
    • Growth in Veterinary Clinics and Pet Hospitals Expands Vaccination Accessibility Across Urban and Rural Areas
    • OEM Collaboration With Animal Health Organizations Supports Development of Multivalent Vaccine Protocols
    • Surge in Canine and Feline Adoption Globally Accelerates Demand for Parvo, Distemper, and Rabies Immunizations
    • OEM Development of Intranasal and Oral Vaccine Formulations Improves Compliance and Reduces Stress
    • Rising Incidence of Vector-Borne Diseases in Companion Animals Strengthens Demand for Tick and Mosquito-Borne Vaccines
    • OEM Emphasis on Cold Chain Infrastructure and Vaccine Stability Supports Global Distribution Readiness
    • Growth in Veterinary Preventive Healthcare Plans Drives Regular Vaccination Schedules
    • OEM Advances in Adjuvant Technology and Immunomodulation Expand Duration of Immunity
    • Regulatory Support for Rabies Elimination Programs Fuels Public-Private Vaccine Initiatives
    • OEM Entry Into Pet Wellness Programs and Vaccine Subscription Models Strengthens Market Penetration
    • Increase in Global Travel With Pets Propels Demand for Travel-Required Vaccination Compliance
    • OEM Investment in Region-Specific Disease Surveillance Enhances Localized Vaccine Portfolio Development
    • Growth in Shelter Medicine and Animal Rescue Initiatives Drives Mass Vaccination Opportunities
    • OEM Focus on Genetic and Breed-Specific Immunization Strategies Expands Personalized Pet Health
    • Expansion of E-Commerce and Veterinary Telehealth Boosts Access to At-Home Vaccination Support Tools
    • Rising Incidence of Vaccine Hesitancy and Over-Vaccination Concerns Spurs Demand for Serological Titer Testing
    • OEM Participation in Global One Health Frameworks Enhances Alignment With Human and Animal Health Surveillance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pet Vaccines Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pet Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Canlane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Canlane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Canlane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Feline by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Dogs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Rabbits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Rabbits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Rabbits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Pet Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Pet Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Pet Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Pet Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION